In May Dr. Abhishek Vartak successfully defended his PhD dissertation. He leaves in June to start postdoctoral work at Memorial Sloan Kettering Cancer Center in New York City.
New N-aryl ureas active against Mtb, M. smegmatis, and M. abscessus were identified. Actives shared a common 1-(cyclohexylmethyl)-3-phenylurea motif. MedChemComm, 2019, DOI: 10.1039/C9MD00122K
In this paper we describe oligosaccharide synthesis on pHEMA. The pHEMA bound oligosaccharides could be readily purified by precipitation or ultrafiltration and carried on to the next step. RSC Advances, 2018, 8, 41612 - 41619 https://pubs.rsc.org/en/Content/ArticleLanding/2018/RA/C8RA08252A#!divAbstract
Time to have some fun, the semester is almost over.
Ms. Saniya Khan has joined the group as a PhD pre-candidate. Welcome!
Ms. Radhika Thanvi has joined the group. Welcome!
Abhishek Vartak’s peer reviewed ACS Symposium Series chapter titled: “Advances in Synthetic Approaches towards Glycoantigens” has been published in Carbohydrate-Based Vaccines: From Concept to Clinic' https://pubs.acs.org/doi/pdf/10.1021/bk-2018-1290.ch008
The Sucheck and Ronning groups have published “Synthesis and in vitro characterization of trehalose‐based inhibitors of mycobacterial trehalose 6‐phosphate phosphatases” in CHEMBIOCHEM. https://onlinelibrary.wiley.com/doi/10.1002/cbic.201800551
Ph.D. Candidate Abhishek Vartak has received a travel award from the ACS Division of Organic Chemistry to present at the 2018 National ACS meeting in Boston. Former undergraduate researcher Ms. Miranda Dermanelian, has been accepted to Law school. Congratulations!